Anti-Idiotypic Agonistic Antibodies: Candidates for the Role of Universal Remedy

Переведенное название: Антиидиотипические антитела-агонисты: кандидаты на роль универсального лекарства

Aliya K. Stanova, Varvara A. Ryabkova, Sergei V. Tillib, Vladimir J. Utekhin, Leonid P Churilov, Yehuda Shoenfeld

Результат исследований: Научные публикации в периодических изданияхОбзорная статьярецензирование

7 Загрузки (Pure)


Anti-idiotypic antibodies (anti-IDs) were discovered at the very beginning of the 20th century and have attracted attention of researchers for many years. Nowadays, there are five known types of anti-IDs: alpha, beta, gamma, epsilon, and delta. Due to the ability of internal-image anti-IDs to compete with an antigen for binding to antibody and to alter the biologic activity of an antigen, anti-IDs have become a target in the search for new treatments of autoimmune illnesses, cancer, and some other diseases. In this review, we summarize the data about anti-IDs that mimic the structural and functional properties of some bioregulators (autacoids, neurotransmitters, hormones, xenobiotics, and drugs) and evaluate their possible medical applications. The immune system is potentially able to reproduce or at least alter the effects of any biologically active endogenous or exogenous immunogenic agent via the anti-idiotypic principle, and probably regulates a broad spectrum of cell functions in the body, being a kind of universal remedy or immunacea, by analogy to the legendary ancient goddess of universal healing Panacea (pi alpha nu alpha kappa epsilon iota alpha, Panakeia in Greek) in the treatment and prevention of diseases, possibly including non-infectious somatic and even hereditary ones.

Переведенное названиеАнтиидиотипические антитела-агонисты: кандидаты на роль универсального лекарства
Язык оригиналаАнглийский
Номер статьи19
Страницы (с-по)19
Число страниц15
ЖурналAntibodies (Basel, Switzerland)
Номер выпуска2
СостояниеОпубликовано - июн 2020


Подробные сведения о темах исследования «Антиидиотипические антитела-агонисты: кандидаты на роль универсального лекарства». Вместе они формируют уникальный семантический отпечаток (fingerprint).